A new biology of diabetes revealed by leptin.

Unger, Roger H; Roth, Michael G · Cell Metab · 2015

review · Level V

Where this comes from

Abstract

A variety of leptin actions require a re-examination of classic concepts of metabolic diseases. Here we present evidence for two physiologic pathways: a pathway that protects nonadipose tissues from overaccumulation of potentially toxic lipids and unrecognized paracrine interactions between α and β cells revealed by leptin's ability to suppress diabetic hyperglucagonemia. These observations strongly point to new therapeutic possibilities for both type 1 and type 2 diabetes.

Medical subject headings